Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 801–900 of 1,004
Off-target identification by chemical proteomics for the understanding of drug side effects
Song, Y., Luo, L., & Wang, K. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1873134 · Cited by 5
TP-MAP - an Integrated Software Package for the Analysis of 1D and 2D Thermal Profiling DataPreprint
Feyertag, F., & Huber, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.22.432361 · Cited by 5
Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assaysPreprint
Vranken, J. G. V., Li, J., Mintseris, J., Wei, T.-Y., Sniezek, C. M., Gadzuk-Shea, M. M., Gygi, S. P., & Schweppe, D. K. (2024) · eLife · doi:10.7554/elife.95595.2 · Cited by 6
Discovery of Novel Aromatic Urea-Imidazole Salt Derivatives for Cancer Therapy via Targeting ERK1/2
Wang, M., Yang, S., Li, X., Zheng, Y., Bai, Y., Luo, W., Zhu, G., Chang, J., & Zhu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01434 · Cited by 5
Discovery of 4,5,6,7-Tetrahydrothieno [3,2-b] Pyridine as Novel Fungicide Lead Scaffold
Chen, K., Deng, D., Yin, Y., Xi, D., Park, P., Gao, W., Liu, R., & Lei, K. (2025) · Microorganisms · doi:10.3390/microorganisms13071588 · Cited by 4
“…such as drug affinity responsive target stability (DARTS) [10], cellular thermal shift assay (CETSA) [11,12], thermal proteome profiling (TPP) [13,14], stability of proteins from rates of oxidation (SPROX) [15], and target identification by chromatographic elution (TICE) [16] have…”
Hage, D. S., Sharmeen, S., Sajeeb, B., Olupathage, H., Rahman, M. M., Kyei, I., Alim, S., & Pinky, N. S. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101407 · Cited by 5
“Proteomics-based techniques such as thermal proteome profiling and chemo-proteomics have also been developed for studying drug-target interactions within complex biological systems [13 – 15].”
Cupp‐Sutton, K. A., Guo, Y., Welborn, T., & Wu, S. (2025) · Journal of Mass Spectrometry · doi:10.1002/jms.5187 · Cited by 4
Yu, T., Wang, Y., Li, Y., Wang, K., Zhu, H., & Ye, M. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03099 · Cited by 4
Yu, T., Wang, Y., Wang, K., Fang, Z., Zhu, H., Zhang, X., Li, Y., & Ye, M. (2025) · Nature Communications · doi:10.1038/s41467-025-65497-2 · Cited by 4
Hussein, M. A., & Munirathinam, G. (2026) · Cancers · doi:10.3390/cancers18050719 · Cited by 10
“When the target remains uncertain despite predictions, TPP provides an unbiased method for identifying proteins with altered thermal stability following compound treatment, revealing both expected and unexpected interactions [148].”
Garrido‐Rodríguez, M., Potel, C. M., Burtscher, M. L., Becher, I., Rodríguez-Mier, P., Müller‐Dott, S., Savitski, M. M., & Sáez-Rodríguez, J. (2026) · Nature Communications · doi:10.1038/s41467-026-69332-0 · Cited by 12
Self-citationZheng, X., Li, Y., Qin, H., Ruan, C., Yao, L., Liu, X., Ye, M., Qu, G., & Jiang, G. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c15707 · Cited by 5
Guo, C., Li, Q., Liang, W., Lu, J., Yue, W., Tian, S., & Zhang, W. (2026) · Targetome · doi:10.48130/targetome-0026-0027 · Cited by 4
Thermal proteome profiling reveals the glial toxicity of dencichine via inhibiting proteasome
Zhang, Q., Liu, G., Li, Y., Yang, B., Guo, W., Zhang, Y., Pan, L., Zhang, P., Zhang, W., & Kong, D. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114146 · Cited by 5
Quantitative Proteomics Reveal the Role of Matrine in Regulating Lipid Metabolism
Feng, H., Liu, G., Li, L., Ren, X., Jiang, Y., Hou, W., Liu, R., Liu, K., Liu, H., & Huang, H. (2024) · ACS Omega · doi:10.1021/acsomega.3c09983 · Cited by 4
“− 42 Considering the practical research requirements, we conducted the TPP experiments only on A549 cells.”
MethodQuantifying protein unfolding kinetics with a high-throughput microfluidic platform
Atsavapranee, B., Sunden, F., Herschlag, D., & Fordyce, P. M. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101681 · Cited by 5
Above-Filter Digestion Proteomics Reveals Drug Targets and Localizes Ligand Binding Site
Sokolova, B., Gharibi, H., Jafari, M. T., Lyu, H., Lovera, S., Gaetani, M., Saei, A. A., & Zubarev, R. A. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00927 · Cited by 5
Kirsch, V. C., Orgler, C., Braig, S., Jeremias, I., Auerbach, D., Müller, R., Vollmar, A. M., & Sieber, S. A. (2019) · Angewandte Chemie · doi:10.1002/ange.201911158 · Cited by 4
Experimental study of proteome halophilicity using nanoDSF: a proof of concept
Carré, L., Girard, É., & Franzetti, B. (2021) · Extremophiles · doi:10.1007/s00792-021-01250-z · Cited by 4
Lu, D., Pan, R., Wu, W., Zhang, Y., Li, S., Xu, H., Huang, J., Xia, J., Wang, Q., Luan, X., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac263 · Cited by 3
Lu, Q., & Russinova, E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_3 · Cited by 4
Hu, Y., Mostert, D., Orgler, C., Andler, O., Zischka, H., Kazmaier, U., Vollmar, A. M., Braig, S., Sieber, S. A., & Zahler, S. (2024) · ChemBioChem · doi:10.1002/cbic.202400024 · Cited by 5
Berryhill, C. A., Doud, E. H., Hanquier, J. N., Smith-Kinnaman, W. R., McCourry, D. L., Mosley, A. L., & Cornett, E. M. (2024) · Biomolecules · doi:10.3390/biom14070817 · Cited by 4
“The basic principle underlying the thermal stability assay is that a given proteoform aggregates at a certain temperature [18].”
BackgroundThe HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2
Howard, J. N., Zaikos, T. D., Levinger, C., Rivera, E., McMahon, E. K., Holmberg, C. S., Terao, J., Sanz, M., Copertino, D. C., Wang, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179680 · Cited by 4
“Here, to identify HODHBt target candidates, we used thermal proteomic profiling (TPP) (9–11).”
BackgroundMethodCharacterizing protein-protein interactions with thermal proteome profiling
Searle, B. C. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102946 · Cited by 6
Chemical Dimerizers in Three-Hybrid Systems for Small Molecule–Target Protein Profiling
Clercq, D. J. H. D., Tavernier, J. H., Lievens, S., & Calenbergh, S. V. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00811 · Cited by 4
Shen, Q., Bhatt, V. S., Krieger, I. V., Sacchettini, J. C., & Cho, J. (2018) · MedChemComm · doi:10.1039/c7md00619e · Cited by 4
Xue, C., Yu, W., Song, H., Huang, X., & Ren, J. (2022) · The Analyst · doi:10.1039/d2an00031h · Cited by 4
Skirycz, A., Caldana, C., & Fernie, A. R. (2022) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2022.2041948 · Cited by 5
“Finally, cellular thermal shift assay (CETSA) and thermal proteome profiling (TPP) determine shifts in protein thermal stability associated with a binding event (Martinez Molina et al., 2013; Savitski et al., 2014; Franken et al., 2015).”
BackgroundSolvent-Induced Protein Precipitation for Drug Target Discovery
Zhang, X., Hu, L., & Ye, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_4 · Cited by 4
The In-Cell Western immunofluorescence assay to monitor PROTAC mediated protein degradation
Lu, L. D., & Salvino, J. M. (2022) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2022.08.012 · Cited by 7
Xu, Y., Zheng, M., Gong, L., Liu, G., Qian, S., Han, Y., & Kang, J. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00867 · Cited by 4
Cheng, Z., Hwang, S. S., Bhave, M. R., Rahman, T., & Wezen, X. C. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01252 · Cited by 4
Biophysical screening and characterisation in medicinal chemistry
Bingham, M. J., Pesnot, T., & Scott, A. D. (2023) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2023.10.002 · Cited by 6
Qin, W., Deng, Y., Ren, H., Liu, Y., Liu, L., Liu, W., Zhao, Y., Li, C., & Yang, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.70252 · Cited by 3
Chemical Biology in Drug Discovery
Castaldi, M. P., Zuhl, A. M., Ricchiuto, P., & Hendricks, J. A. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.08.009 · Cited by 6
Unmodified methodologies in target discovery for small molecule drugs: A rising star
Tang, J., Ou, M., Zheng, Q., & Ding, Y. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.04.013 · Cited by 4
Contemporary Techniques for Target Deconvolution and Mode of Action Elucidation
Schirle, M., & Jenkins, J. L. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160721-00083 · Cited by 4
Proteome-wide identification of amino acid substitutions deleterious for protein functionPreprint
Rodríguez‐Mias, R. A., Hess, K. N., Ruiz, B. Y., Smith, I. R. L., Barente, A. S., Zimmerman, S. M., Lu, Y. Y., Noble, W. S., Fields, S., & Villén, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.06.487405 · Cited by 4
“To do this, we generated a statistical proteome with 5-10% azetidine incorporation in proline positions and implemented thermal proteome profiling (TPP) 18 , a proteomics assay that measures protein thermal stability of thousands of proteins by mass spectrometry.”
MethodCharacterization of novel dual PTPN1 and PTPN2 inhibitorsPreprint
Bosque, A., Howard, J. N., Zaikos, T. D., Levinger, C., Rivera, E., McMahon, E. K., Sanz, M., Copertino, D. C., Wang, W., Soriano-Sarabia, N., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2869323/v1 · Cited by 4
STREAMLINED PROTEOME-WIDE IDENTIFICATION OF DRUG TARGETS INDICATES ORGAN-SPECIFIC ENGAGEMENTPreprint
Batth, T. S., Locard‐Paulet, M., Doncheva, N. T., Mendez, B. L., Jensen, L. J., & Olsen, J. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.08.578880 · Cited by 4
“One method that has garnered substantial interest and adoption for cellular drug target deconvolution is thermal proteome profiling (TPP), which integrates the cellular thermal shift assay with mass spectrometry-based proteome profiling for target identification 8,9 .”
MethodWalunjkar, N., Lai, T. Y., Akhter, N., Miller, J. H., Bettinger, J. Q., Marcus, E., Phizicky, E. M., Ghaemmaghami, S., & Fay, J. C. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf137 · Cited by 3
Thermal Proteome Profiling Reveals Meltome Upon NLRP3 Inflammasome Activation
Yang, C., Wang, L., Liu, Y., Zhang, Y., Jin, C., Cheng, J., Shang, L., Fang, L., Wu, S., Chen, C., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100972 · Cited by 3
“…spectrometry (MS), has been widely utilized to reveal context-speci fi c changes in protein states, including the identi fi cation of drug targets (20, 21), metabolites binding proteins (22), and peptide-associated proteins (23), as well as large-scale assessments of protein dynamics throughout…”
Wang, B.-K., Wang, R., Zhuo, F., Wang, J.-K., Huang, Y.-L., Tu, P., Zeng, K., & Li, J. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177789 · Cited by 3
Global protein-ligand binding affinity profiling via photocatalytic labeling
Warren, C. D., Yardeny, N., Peng, S., Burdette, C. S., & Geri, J. B. (2026) · Nature Communications · doi:10.1038/s41467-026-72238-6 · Cited by 8
“Methods for measuring the strength and speci fi city of protein-ligand interactions are of central importance in biology.”
High-throughput proteome integral solubility alteration assay for low cell input using One-Tip
Lechner, M. Y., Sabatier, P., & Olsen, J. V. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01670-4 · Cited by 3
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer
Tailor, D., Garcia-Marques, F. J., Bermudez, A., Rolig, A. S., Grau, B. W., Dheeraj, A., Nambiar, D. K., Li, W., Stefan, K., Campbell, S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102451 · Cited by 4
Chen, H., Liu, H., Tian, Y., Liu, Y., Tang, F., Huang, J., Peng, W., & Yang, J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00565 · Cited by 3
Ma, Y., Zhou, J., Guan, B., Zhang, X., Wang, J., Yan, J., Wang, K., & Ye, M. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05384 · Cited by 3
Dai, M., Wang, Y., Dong, H.-K., Xu, X., Wang, J.-X., Zhu, G.-Q., & Zheng, F. (2026) · Redox Report · doi:10.1080/13510002.2026.2622255 · Cited by 4
“CETSA was used to examine the ligand binding in living cells [34].”
Yamanashi, Y., & Kanai, M. (2026) · Chemical Society Reviews · doi:10.1039/d6cs00107f · Cited by 3
Characterizing Drug–Target Interactions: Shifting towards the Clinic
Schirle, M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.03.001 · Cited by 3
Jin, J., Liang, X., Bi, W., Liu, R., Zhang, S., He, Y., Xie, Q., Liu, S., Xiao, J., & Zhang, P. (2023) · Pharmaceuticals · doi:10.3390/ph16121705 · Cited by 3
Using protein–metabolite interactions to identify novel plant metabolite receptors
Fischer, H. D., Fernie, A. R., & Skirycz, A. (2024) · Phytochemistry Reviews · doi:10.1007/s11101-024-10005-5 · Cited by 5
“…(Lomenick et al. 2009; Piazza et al. 2018, 2020), whereas cellular thermal shift assay (CETSA), thermal proteome profiling (TPP) and isothermal shift assay (iTSA) look for the shift in thermal stability of proteins after ligand binding (Molina et al. 2013; Savitski et al. 2014; Ball et al. 2020).”
Wiest, A., & Kielkowski, P. (2024) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.20.199 · Cited by 3
Korovesis, D., Mérillat, C., Derua, R., & Verhelst, S. H. L. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01436-y · Cited by 2
Application of mass spectrometry for the advancement of PROTACs
Hao, Y., Zhang, B., & Chen, R. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116829 · Cited by 4
Systematic screen uncovers regulator contributions to chemical cues in Escherichia coli
Binsfeld, C., Olayo-Alarcón, R., Jiménez, L. P., Wartel, M., Stadler, M., Mateus, A., Müller, C. L., & Brochado, A. R. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003260 · Cited by 5
“Next, we used in vivo thermal proteome profiling (TPP [54–57]), aiming to find caffeine-induced protein thermal stability changes that could explain the observed phenotype.”
Practical Considerations for Omics Experiments in Biomedical Sciences
Vaudel, M., Barsnes, H., Bjerkvig, R., Bikfalvi, A., Selheim, F., Berven, F. S., & Daubon, T. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201016666150817095348 · Cited by 3
Label-Free Target Identification and Confirmation Using Thermal Stability Shift Assays
Rodríguez-Furlán, C., & Hicks, G. R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0954-5_14 · Cited by 3
Ma, E. J., & Kummer, A. (2021) · Entropy · doi:10.3390/e23060727 · Cited by 3
“The key analysis "safeguards" that the meltome authors used to call a non-melter, and hence assign no melting temperature to a protein, was a combination of a threshold value for the lower-bound and a normalized area under the curve value [8,9].”
BackgroundAlectinib treatment improves photodynamic therapy in cancer cell lines of different origin
Gillissen, B. F., Richter, A., Eßmann, F., & Kemmner, W. (2021) · BMC Cancer · doi:10.1186/s12885-021-08667-x · Cited by 3
Ellingson, B. M., Wen, P. Y., & Cloughesy, T. F. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000543 · Cited by 3
Schmidt, A., & Antelo-Varela, M. (2022) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2022.81 · Cited by 4
Schmidt, A., & Schreiner, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2521-7_14 · Cited by 4
Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_12 · Cited by 3
Quantitative Proteomics Explore the Potential Targets and Action Mechanisms of Hydroxychloroquine
Zhao, J., Zhao, Z., Hou, W., Jiang, Y., Liu, G., Ren, X., Liu, K., Liu, H., Chen, K., & Huang, H. (2022) · Molecules · doi:10.3390/molecules27165175 · Cited by 3
“Because HCQ may change the stability of its binding proteins, we can identify the potential binding partners by determining the melting curve shift through thermal proteome profiling [18].”
BackgroundMulti-comparative Thermal Proteome Profiling Uncovers New O-GlcNAc Proteins in a System-wide Method
Wang, G., Li, Y., Wang, T., Wang, J., Yao, J. H., Yan, G., Zhang, Y., & Lu, H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03371 · Cited by 3
Thermal proteome profiling unveils protein targets of deoxycholic acid in living neuronal cells
Luan, H., Li, X., Zhang, W., & Luan, T. (2023) · Advanced Biotechnology · doi:10.1007/s44307-023-00007-3 · Cited by 3
“Thermal proteome profiling (TPP) is a relatively new and powerful tool in the field of proteomics that allows for the identification of protein–ligand interactions in cell lysates, tissues, or living cells (Savitski et al. 2014; Zhong et al. 2021).”
BackgroundMethodInfluentialI’m Walking into Spiderwebs: Making Sense of Protein–Protein Interaction Data
Skawinski, C. L. S., & Shah, P. S. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00892 · Cited by 3
Salmonella infection impacts host proteome thermal stability
Birk, M. S., Walch, P., Baykara, T., Sefried, S., Amelang, J., Buerova, E., Breuer, I., Vervoorts, J., Typas, A., Savitski, M. M., et al. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151448 · Cited by 3
Self-citationStapled Peptides as Inhibitors of mRNA Deadenylation
Pal, S., Gordijenko, I., Schmeing, S., Biswas, S., Akbulut, Y., Gasper, R., & Hart, P. ‘. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202413911 · Cited by 3
Thankan, R. S., Thomas, E. B., Weldemariam, M. M., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Wang, B., Weber, D. J., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70009 · Cited by 3
Zhang, Z., Li, S., Li, F., Shi, Q., Tan, C., Wang, X., Li, M., Liu, Y., Jin, J., Li, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202413676 · Cited by 4
Solubility based mechanistic profiling of combinatorial drug therapy
Gholizadeh, E., Zangene, E., Vadadokhau, U., Ritz, D., Miettinen, J. J., Soliymani, R., Baumann, M., Wilhelm, M., Kankuri, E. M., Haynes, P. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70394-3 · Cited by 8
Schiedel, M., Moroglu, M., Ascough, D. M. H., Chamberlain, A. E. R., Kamps, J. J. A. G., Sekirnik, A. R., & Conway, S. J. (2019) · Angewandte Chemie · doi:10.1002/ange.201812164 · Cited by 3
CELLULAR TARGET ENGAGEMENT ASSAYS FOR SMALL-MOLECULE DRUG DISCOVERY
Delwig, A., Ishisoko, N., & Blake, R. A. (2022) · Medicinal chemistry reviews · doi:10.1021/mc-2022-vol57.ch17 · Cited by 3
Xu, S., Ye, Z., Shang, S., Wang, F., Zhang, H., Chen, L., Lin, H., Chen, C., Hua, F., & Zhang, C. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109034 · Cited by 3
Stein, B. D., Huang, J., Wu, D., Cantley, L. C., & Moellering, R. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.01.441686 · Cited by 3
Deep thermal proteome profiling for detection of proteoforms and drug sensitivity biomarkersPreprint
Kurzawa, N., Stahl, M. M. S., Leo, I. R., Kunold, E., Becher, I., Audrey, A., Mermelekas, G., Huber, W. K., Mateus, A., Savitski, M. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.495491 · Cited by 3
Self-citationSueur, C. L., Rattray, M., & Savitski, M. M. (2024) · bioRxiv · doi:10.1101/2023.10.26.564129 · Cited by 2
Self-citationLarge-scale characterization of drug mechanism of action using proteome-wide thermal shift assaysPreprint
Vranken, J. G. V., Li, J., Mintseris, J., Gadzuk-Shea, M. M., Gygi, S. P., & Schweppe, D. K. (2024) · eLife · doi:10.7554/elife.95595.1 · Cited by 3
Yang, Y., Liu, Y., Wang, L., Liang, J., Zhang, H., Zhang, Z., Zhu, R., Xu, W., Xu, S., Sun, D., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-0gmkw · Cited by 2
Ferreira, I. C., Torrejón, E., Abecasis, B., Alexandre, B. M., Gomes, R. A., Verslype, C., van Pelt, J. F., Barbas, A., Simão, D. F., Bandeiras, T. M., et al. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.100154 · Cited by 2
“…is an updated format of this technology in which protein detection is performed by multiplexed quantitative mass spectrometry (MS), enabling a proteome-wide monitoring of changes in thermal stability induced by the compound under investigation, with a potential of finding unknown targets [17].”
BackgroundMethodAnalysis of Brain Protein Stability Changes in a Mouse Model of Alzheimer’s Disease
Tang, Y., Park, H.-J., Li, S., & Fitzgerald, M. C. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00406 · Cited by 3
Revealing novel protein interaction partners of glyphosate in Escherichia coli
Aldehoff, A. S., Türkowsky, D., Lohmann, P., Homsi, M. N., Rolle-Kampczyk, U. E., Ueberham, E., Lehmann, J., von Bergen�, M., Jehmlich, N., & Haange, S. (2024) · Environment International · doi:10.1016/j.envint.2024.109243 · Cited by 5
Jin, L., Zhang, W., Zeng, K., Li, C., He, J., Li, X., Yang, R., Chi, J., Hong, Z., Wang, W., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70438 · Cited by 2
Validation of solvent proteome profiling for antimalarial drug target deconvolution
Ji, Y., Morrow, J. P., MacRaild, C. A., Zhang, H., Giannangelo, C., Schittenhelm, R. B., Creek, D. J., & Siddiqui, G. (2025) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2025.100626 · Cited by 3
“TPP/CETSA have been adapted for live-cell analysis and have demonstrated their utility in mapping drug-target interactions within intact human cells and parasites (Dziekan et al., 2020; Savitski et al., 2014).”
MAP-X reveals distinct protein complex dynamics across Plasmodium falciparum blood stages
Pažický, S., Tjia, S., Farias, G. B., Piwon, N., Philip, N., Sobota, R. M., Waters, A. P., Gilberger, T., & Bozdech, Z. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02173-7 · Cited by 4
Ramos, P. Z., Catta‐Preta, C. M. C., & Couñago, R. M. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103194 · Cited by 2
Proteome-wide dose-response measurements for the characterization of drug mechanism of action
Berner, N., Bayer, F. P., George, A. L., Kabella, N., Bergamasco, F. L., & Küster, B. (2026) · Targetome · doi:10.48130/targetome-0025-0011 · Cited by 3
Covalent modification of a glutamic acid inspired by HaloTag technology
Zhang, R., Liu, J., Gasper, R., Unger, A., Kaschani, F., Kaiser, M., Janning, P., & Waldmann, H. (2026) · Nature Communications · doi:10.1038/s41467-026-68999-9 · Cited by 5
Thermal Proteome Profiling Identifies New Drug Targets in Plasmodium falciparum Parasites
Pažický, S., Dziekan, J. M., Tjia, S., Bopp, S. E. R., Wirth, D. F., Preiser, P. R., & Bozdech, Z. (2026) · Molecular & Cellular Proteomics · doi:10.64898/2026.01.30.702724 · Cited by 3
“2a-b), their ranking depends on the ability of the individual proteins to be stabilized by drug binding 25 .”
Advancing DIA-Based Limited Proteolysis Workflows: Introducing DIA-LiPA
Leene, C. V., Araftpoor, E., Staes, A., Argentini, A., Bühler, M., Clement, L., & Gevaert, K. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07014 · Cited by 2
“…been developed for this purpose, including cross-linking mass spectrometry (XL-MS), 5,6 hydrogen − deuterium exchange mass spectrometry (HDX-MS), 7 thermal proteome profiling (TPP), 8,9 peptide-centric local stability assay (PELSA) 10 and limited proteolysis coupled to mass spectrometry (LiP-MS).”
Lehe, M. D., Almofeez, R., Jeffery, E. D., & Sheynkman, G. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70024 · Cited by 4
The emerging role of high-throughput proteomics in advancing precision medicine
You, J., Deng, Y., Chen, L., Wang, L., Guo, Y., Li, Z.-Y., Feng, J., Yu, Y., & Cheng, W. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.02.054 · Cited by 4
Need for speed: advances in the era of high throughput interaction proteomics
Frommelt, F., Uliana, F., Aebersold, R. H., & Fossati, A. (2026) · Molecular Omics · doi:10.1093/molecular-omics/aaiag012 · Cited by 3
Ni, Z., Shi, Y., & Rao, Y. (2026) · Targetome · doi:10.48130/targetome-0026-0019 · Cited by 3
The CLOCK–BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting
Kamel, E. M., Khadrawy, S. M., Allam, A. A., Ahmed, N. A., Alkhayl, F. F. A., & Lamsabhi, A. M. (2026) · Inflammation Research · doi:10.1007/s00011-026-02275-w · Cited by 3
“They are particularly valuable for BMAL1 PAS-B chemistry, where CETSA readouts on BMAL1 variants pin-point the on-target effect of CCM-like ligands [ 44].”
Fifteen challenges for generative AI applications to cell biology
Dupire, L., Khan, A. A., Karaletsos, T., Kelley, S., Lundberg, E. K., Ma, J., Paull, E., Quake, S. R., Rabadán, R., Cassius, R., et al. (2026) · Cell · doi:10.1016/j.cell.2026.07.004 · Cited by 4
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.